Needham Reiterates Buy on DocGo, Maintains $14 Price Target
Portfolio Pulse from richadhand@benzinga.com
Needham analyst Ryan MacDonald has reiterated a 'Buy' rating on DocGo (NASDAQ:DCGO) and maintained a price target of $14.
August 22, 2023 | 11:49 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Ryan MacDonald has reiterated a 'Buy' rating on DocGo and maintained a price target of $14.
The reiteration of a 'Buy' rating by a Needham analyst and the maintenance of a $14 price target indicates a positive outlook for DocGo. This could potentially lead to an increase in investor confidence and a positive impact on the stock's short-term price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100